Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zanger

Showing results (171-180 of 203) with videos related to

Pageof 21
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2008
Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liverNina Kassner, Klaus Huse, Hans-Jörg Martin, et al.
Antimicrobial Agents and Chemotherapy|May 14, 2014
Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6Michael H Court, Fawziah E Almutairi, David J Greenblatt, et al.
Cellular Signalling|January 7, 2015
Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2Christian Ehlting, Oliver Böhmer, Maximilian J Hahnel, et al.
BMC Systems Biology|November 22, 2015
Pathobiochemical signatures of cholestatic liver disease in bile duct ligated miceKerstin Abshagen, Matthias König, Andreas Hoppe, et al.
Clinical Pharmacology and Therapeutics|January 20, 2007
Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individualsM Rotger, H Tegude, S Colombo, et al.
Journal of the American Society of Nephrology : JASN|March 18, 2005
ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantationIngeborg A Hauser, Elke Schaeffeler, Stefan Gauer, et al.
JAMA|March 24, 2005
Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemiaMartin Stanulla, Elke Schaeffeler, Thomas Flohr, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 9, 2018
Unexpected Effects of Propiconazole, Tebuconazole, and Their Mixture on the Receptors CAR and PXR in Human Liver CellsConstanze Knebel, Jannika Neeb, Elisabeth Zahn, et al.
Pharmacogenetics and Genomics|October 19, 2006
Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokineticsMikko Niemi, Katja A Arnold, Janne T Backman, et al.
The Journal of Biological Chemistry|April 10, 2002
Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestineOliver Burk, Heike Tegude, Ina Koch, et al.
Pageof 21

Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2008
Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liverNina Kassner, Klaus Huse, Hans-Jörg Martin, et al.
Antimicrobial Agents and Chemotherapy|May 14, 2014
Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6Michael H Court, Fawziah E Almutairi, David J Greenblatt, et al.
Cellular Signalling|January 7, 2015
Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2Christian Ehlting, Oliver Böhmer, Maximilian J Hahnel, et al.
BMC Systems Biology|November 22, 2015
Pathobiochemical signatures of cholestatic liver disease in bile duct ligated miceKerstin Abshagen, Matthias König, Andreas Hoppe, et al.
Clinical Pharmacology and Therapeutics|January 20, 2007
Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individualsM Rotger, H Tegude, S Colombo, et al.
Journal of the American Society of Nephrology : JASN|March 18, 2005
ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantationIngeborg A Hauser, Elke Schaeffeler, Stefan Gauer, et al.
JAMA|March 24, 2005
Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemiaMartin Stanulla, Elke Schaeffeler, Thomas Flohr, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 9, 2018
Unexpected Effects of Propiconazole, Tebuconazole, and Their Mixture on the Receptors CAR and PXR in Human Liver CellsConstanze Knebel, Jannika Neeb, Elisabeth Zahn, et al.
Pharmacogenetics and Genomics|October 19, 2006
Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokineticsMikko Niemi, Katja A Arnold, Janne T Backman, et al.
The Journal of Biological Chemistry|April 10, 2002
Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestineOliver Burk, Heike Tegude, Ina Koch, et al.
Pageof 21